A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk
Andrea Manfrin,1 Valentina Trimarco,2,3 Maria Virginia Manzi,2,4 Francesco Rozza,2,4 Raffaele Izzo2,5 1Sussex Pharmacy, School of Life Sciences, University of Sussex, Falmer, Brighton, UK; 2Hypertension Research Centre, University of Naples Federico II, Naples, Italy; 3Department o...
Spremljeno u:
Glavni autori: | , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Dove Medical Press,
2018-10-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |